Media formats available:
Recommended
- CDMC 2018: Shifting gears in the management of diabetes and CVDTwo choices of drugs that reduce CV risk in T2DM
- CDMC 2018: Shifting gears in the management of diabetes and CVDTranslating mechanisms of GLP-1RAs and SGLT2 inhibitors to CV benefits
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Targeting CV risk: Implications for clinical management of patients with T2DM & CVD